Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000989513 | SCV001139926 | uncertain significance | Rubinstein-Taybi syndrome due to CREBBP mutations | 2019-05-28 | criteria provided, single submitter | clinical testing | |
UNC Molecular Genetics Laboratory, |
RCV000989513 | SCV001423841 | uncertain significance | Rubinstein-Taybi syndrome due to CREBBP mutations | criteria provided, single submitter | research | CREBBP c.283G>A, [p.V95M] has not been reported previously in the medical literature, and is a variant of uncertain significance. | |
Gene |
RCV001655658 | SCV001871280 | likely benign | not provided | 2021-07-15 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 8616895, 27535533, 29259186) |
Labcorp Genetics |
RCV002550613 | SCV003452853 | likely benign | Rubinstein-Taybi syndrome | 2023-04-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001655658 | SCV004033453 | uncertain significance | not provided | 2024-01-01 | criteria provided, single submitter | clinical testing | CREBBP: PP2 |